Javier Marcelo Di Noia

Javier Marcelo Di Noia

Auto-generated profile, based on publicly available information

Javier Marcelo Di Noia

Institut de recherches cliniques de Montréal (IRCM), Montréal, Canada

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2007 in Annual Review of Biochemistry
Verified
Journal Article
Closed access
JNJavier M. Di Noia
Javier M. Di Noia
MNMichael S. Neuberger
Michael S. Neuberger
Functional antibody genes are assembled by V-D-J joining and then diversified by somatic hypermutation. This hypermutation results from stepwise incorporation of single nucleotide substitutions into the V gene, underpinning much of antibody diversity and affinity maturation. Hypermutation is triggered by activation-induced deaminase (AID), an enzyme which catalyzes targeted deamination of deoxycytidine residues in DNA. The pathways used for processing the AID-generated U:G lesions determine the variety of base substitutions observed during somatic hypermutation. Thus, DNA replication across the uracil yields transition mutations at C:G pairs, whereas uracil excision by UNG uracil-DNA glycosylase creates abasic sites that can also yield transversions. Recognition of the U:G mismatch by MSH2/MSH6 triggers a mutagenic patch repair in which polymerase eta plays a major role and leads to mutations at A:T pairs. AID-triggered DNA deamination also underpins immunoglobulin variable (IgV) gene conversion, isotype class switching, and some oncogenic translocations in B cell tumors.

31 July 2002 in Nature
Verified
Journal Article
Closed access
PDF file
JNJavier Di Noia
Javier Di Noia
MNMichael S. Neuberger
Michael S. Neuberger

1 October 2004 in Molecular Cell
Verified
Journal Article
Closed access
CRCristina Rada
Cristina Rada
JNJavier M. Di Noia
Javier M. Di Noia
MNMichael S. Neuberger
Michael S. Neuberger

17 December 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HYHelen Yu
Helen Yu
HPHelen Pak
Helen Pak
IHIan Hammond-Martel
Ian Hammond-Martel
MGMehdi Ghram
Mehdi Ghram
ARAmélie Rodrigue
Amélie Rodrigue
EAEl Bachir Affar
El Bachir Affar
Significance: BAP1 is a deubiquitinase of histone H2A involved in chromatin remodeling. Several studies identified BAP1 as major tumor suppressor inactivated in various cancers. Nonetheless, the manner in which BAP1 protects against cancer development remains enigmatic. We now show that BAP1 is recruited to double-strand DNA break sites and promotes error-free repair of these lesions. We also provide the first evidence that phosphorylation coordinates the function of BAP1 in promoting cellular recovery from DNA damage. Thus, our study represents a significant advance in the field of ubiquitin signaling in the context of cancer development.

1 March 2006 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CBCarlos A. Buscaglia
Carlos A. Buscaglia
VCVanina A. Campo
Vanina A. Campo
AFAlberto C. C. Frasch
Alberto C. C. Frasch
JNJavier M. Di Noia
Javier M. Di Noia